Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul:243:108129.
doi: 10.1016/j.rmed.2025.108129. Epub 2025 Apr 28.

Neuromodulation of dyspnea - A literature review

Affiliations
Free article
Review

Neuromodulation of dyspnea - A literature review

Sandrine Massé et al. Respir Med. 2025 Jul.
Free article

Abstract

Dyspnea is a complex sensation resulting from the interplay between neural, biochemical, and mechanical pathways. Because dyspnea is a perception created and interpreted by the central nervous system, it could theoretically be targeted by neuromodulation approaches. This technique is used in pain to modulate the function of neuronal circuits. However, a safe surgical and/or non-invasive modus operandi is not established for refractory dyspnea. Nevertheless, the following literature review will discuss different neuromodulation techniques that may treat refractory dyspnea, even though the understanding of its pathophysiology is limited. More precisely, the diaphragm and its phrenic control, the ventral respiratory complexes (such as Kolliker-Fuse complex and the pre-Bötzinger complex), the vagal nerve, the periaqueductal gray, the insula, the cingular cortex, and the thalamus appear to play an important role in the pathophysiology of breathlessness. Consequently, deep brain stimulation, trigeminal nerve, spinal and vagal nerve stimulations are potentially effective approaches to diminish dyspnea. The discovery of useful dyspnea-reducing neuromodulation techniques could replace or be added to actual treatments like pulmonary rehabilitation, facial ventilators, oxygen, and opioids could be replaced, consequently enhancing the quality of life of dyspneic individuals.

Keywords: DBS; Dyspnea; Neuromodulation; Pathophysiology; Treatment; VNS.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: SM, JSP, TD: have no conflict to declare CIM reports the following: he is a clinical research scholar of the Fonds de recherche du Québec; he has received consulting fees from Novus Health, Kriya Therapeutics, and Edge Therapeutics. He is an advisory board member and has, or will have stock options for Infinéis Médical, Axcell Labs, and Carbon Cybernetics; he is the medical director of EncephalX and Abaxial Medical; he is founder and president of Hyperexis. FAV reports speaker and consulting honoraria from AstraZenaca, Sanofi-Regeneron, GlaxoSmithKline, Boehringer Ingelheim, Novartis and Grifols outside of the submitted work. SC reports the following: he has received non-restricted research grants from the NIHR Oxford BRC, the Quebec Respiratory Health Research Network, the Association Pulmonaire du Québec, the Academy of Medical Sciences, AstraZeneca, bioMérieux, Circassia Niox Group, and Sanofi-Genyme-Regeneron; he is the holder of the Association Pulmonaire du Québec’s Research Chair in Respiratory medicine and is a Clinical research scholar of the Fonds de recherche du Québec; he received speaker honoraria from AstraZeneca, GlaxoSmithKline, Sanofi-Regeneron, and Valeo Pharma; he received consultancy fees for FirstThought, AstraZeneca, GlaxoSmithKline, Sanofi-Regeneron, Access Biotechnology and Access Industries; he has received sponsorship to attend/speak at international scientific meetings by/for AstraZeneca and Sanofi-Regeneron. He is an advisory board member and detains stock options for Biometry Inc – a company which is developing a FeNO device (myBiometry). He advised the Institut national d'excellence en santé et services sociaux (INESSS) for an update of the asthma general practice information booklet for general practitioners, and is a member of the asthma steering committee of the Canadian Thoracic Society.

LinkOut - more resources